Cargando…

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis

Minimal hepatic encephalopathy (MHE) is a frequent neurological and psychiatric complication of liver cirrhosis. The precise pathogenesis of MHE is complicated and has yet to be fully elucidated. Studies in cirrhotic patients and experimental animals with MHE have indicated that gut microbiota dysbi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ming, Xin, Rui-Juan, Hu, Fang-Rui, Yao, Li, Hu, Sheng-Juan, Bai, Fei-Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850958/ https://www.ncbi.nlm.nih.gov/pubmed/36683714 http://dx.doi.org/10.3748/wjg.v29.i1.144

Ejemplares similares

The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
por: Zhu, Ruirui, et al.
Publicado: (2023)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023)

Diabetes and gut microbiota
por: Xi, Yue, et al.
Publicado: (2021)

Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
por: Moran, Segundo, et al.
Publicado: (2021)

Quality of life in patients with minimal hepatic encephalopathy
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Gut microbiota in obesity
por: Liu, Bing-Nan, et al.
Publicado: (2021)

Potential role of the gut microbiota in synthetic torpor and therapeutic hypothermia
por: Sisa, Claudia, et al.
Publicado: (2017)

Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus
por: Kant, Ravi, et al.
Publicado: (2022)

Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
por: Nardelli, Silvia, et al.
Publicado: (2019)

Gut microbiota mediated molecular events and therapy in liver diseases
por: Qi, Xiaoqiang, et al.
Publicado: (2020)

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
por: Liu, Jiachen, et al.
Publicado: (2021)

The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021)

Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
por: Wang, Ming-Wei, et al.
Publicado: (2023)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Update on gut microbiota in gastrointestinal diseases
por: Nishida, Atsushi, et al.
Publicado: (2022)

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
por: Nishida, Atsushi, et al.
Publicado: (2021)

The gut microbiota and its interactions with cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Role of gut microbiota via the gut-liver-brain axis in digestive diseases
por: Ding, Jian-Hong, et al.
Publicado: (2020)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Gut microbiota and COVID-19: An intriguing pediatric perspective
por: Valentino, Maria Sole, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis
por: Luo, Ming, et al.
Publicado: (2020)

Exploring the food-gut axis in immunotherapy response of cancer patients
por: Russo, Edda, et al.
Publicado: (2020)

Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
por: Ahsan, Khansa, et al.
Publicado: (2023)

The Microbiota-Gut-Brain Axis in Sepsis-Associated Encephalopathy
por: Gareau, Mélanie G.
Publicado: (2022)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome
por: Chen, Si-Yue, et al.
Publicado: (2022)

Interaction between gut microbiota and COVID-19 and its vaccines
por: Leung, John S M
Publicado: (2022)

The Link between Gut Microbiota and Hepatic Encephalopathy
por: Won, Sung-Min, et al.
Publicado: (2022)

Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients
por: Zuo, Zan, et al.
Publicado: (2017)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota
por: Bauer, Eugen, et al.
Publicado: (2018)

Gut microbiota in common elderly diseases affecting activities of daily living
por: Shimizu, Yukihiro
Publicado: (2018)

Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
por: Yang, Jiayue, et al.
Publicado: (2020)

Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity
por: Wei, Yan-Xia, et al.
Publicado: (2021)

The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
por: Kim, Jaeho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_akvmghn3cgj3re4c2jhm3tl6oj